Show simple item record

dc.contributor.supervisor Turner, Donna (Community Health Sciences) en_US
dc.contributor.author Paulson, Charles
dc.date.accessioned 2016-09-26T12:43:40Z
dc.date.available 2016-09-26T12:43:40Z
dc.date.issued 2016
dc.identifier.uri http://hdl.handle.net/1993/31859
dc.description.abstract We sought to understand whether giving patients additional consolidation chemotherapy prior to transplant might be an effective tool to reduce the risk of relapse after transplant through the use of a large retrospective database. A theoretical framework was developed based on previous publications to help guide the project. Potential confounding variables from the database were identified using this theoretical framework. Patients who received consolidation chemotherapy prior to transplant were compared to patients who did not receive consolidation chemotherapy. After multivariate analysis, there was no difference in overall survival between groups. This study suggests that clinicians should not routinely administer consolidation chemotherapy with the aim of reducing relapse rates and improving outcomes after transplant en_US
dc.subject leukemia en_US
dc.subject transplant en_US
dc.title The Role of Consolidation in Reduced Intensity Transplantation for Acute Myeloid Leukemia en_US
dc.degree.discipline Community Health Sciences en_US
dc.contributor.examiningcommittee Czaykowski, Piotr (Internal Medicine) Mahmud, Salah (Community Health Sciences) Eapen, Mary (Medical College of Wisconsin) en_US
dc.degree.level Master of Science (M.Sc.) en_US
dc.description.note October 2016 en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

View Statistics